As the countries have already started their vacAs the countries have already started their vaccination drive, they are also figuring out ways to ensure that not only the vaccinations are being administered but also are effective on people. A new study has revealed that AstraZeneca-Oxford University Covid-19 vaccines are more effective if administered in the gap of 12 weeks between first and second doses.

The study was published in the Lancet medical journal on Friday and revealed that if there is a 12-week gap between the first and dose then the protection against serious illness due to coronavirus increases by 81 percent which is 26 percent more than the protection guaranteed earlier.

It only guaranteed 55 percent protection earlier when the doses were being administered in the gap of six weeks. The latest findings have backed the approach taken by the United Kingdom, which extends the window of dosage by three months.

The move was initiated so that more people are able to get the vaccination, an approach welcomed by the World Health Organisation. Experts believe that this three-month gap is the reason for Britain becoming a successful model especially when the vaccination drive by the UK is compared to other nations.

The UK, as of now, has already administered vaccination to 16.4 million people and is behind only Israel and the United Arab Emirates if the inoculation per capita is being considered, confirm the statistics given by the government websites.

The study was done on 17,000 people also added that a single dose of the vaccine only guarantees protection up to 76 percent in the first three months but the second dose offers protection up to 81 percent. This study may be beneficial for the nations who are either administering or will be administering this particular vaccine in the coming days.

Prof Andrew Pollard, who is the chief investigator of Oxford vaccine group, also said that a gap of 12 weeks can achieve the greatest safety and ensure public health. “Where there is a limited supply, policies of initially vaccinating more people with a single dose may provide greater immediate population protection than vaccinating half the number of people with two doses.”

He explained that the second dose must ensure a long-lived immunity among individuals and hence everyone who has been administered the first vaccine dose must ensure that the second dose should also be taken.

It was revealed that in the 22 days when the study’s participants received their first dose of vaccine, not even a single patient was admitted to the hospital. Among them, 15 people were among those who received a placebo. Out of the 8,597 who received vaccines, 8,581 were injected with a placebo.

He also added, “If the vaccine had no impact on transmission, we would expect that the number of positive tests in our trial would be the same in vaccine and control groups.”ation drive, they are also figuring out ways to ensure that not only the vaccinations are being administered but also are effective on people. A new study has revealed that AstraZeneca-Oxford University Covid-19 vaccines are more effective if administered in the gap of 12 week between first and second doses.

The study was published in the Lancet medical journal on Friday and revealed that if there is a 12 week gap between the first and dose then the protection against serious illness due to coronavirus increases by 81 percent which is 26 per cent more than the protection guaranteed earlier.

It only guaranteed 55 per cent protection earlier when the doses were being administered in the gap of six weeks. The latest findings have backed the approach taken by the United Kingdom, which extends the window of dosage by three months.

The move was initiated so that more people are able to get vaccination, an approach welcomed by the World Health Organisation. Experts believe that this three month gap is the reason for Britain becoming a success model especially when the vaccination drive by the UK is compared to other nations.

The UK, as of now, has already administered vaccination to 16.4 million people and is behind only Israel and the United Arab Emirates if the inoculation per capita is being considered, confirm the statistics given by the government websites.

The study done on 17,000 people also added that a single dose of vaccine only guarantees protection up to 76 percent in the first three months but the second dose offers protections up to 81 percent. This study may be beneficial for the nations who are either administering or will be administering this particular vaccine in coming days.

Prof Andrew Pollard, who is the chief investigator of Oxford vaccine group, also said that a gap of 12 week can achieve greatest safety and ensure public health. “Where there is a limited supply, policies of initially vaccinating more people with a single dose may provide greater immediate population protection than vaccinating half the number of people with two doses.”

He explained that the second dose must ensure a long lived immunity among individuals and hence everyone who has been administered the first vaccine dose must ensure that the second dose should also be taken.

It was revealed that in the 22 days when the study’s participants received their first dose of vaccine, not even a single patient was admitted to hospital. Among them, 15 people were among those who received placebo. Out of the 8,597 who received vaccines, 8,581 were injected with a placebo.

He also added, “If the vaccine had no impact on transmission, we would expect that the number of positive tests in our trial would be the same in vaccine and control groups.”